Maren McBride is named as a lobbyist on federal disclosure filings for 13 clients through Dla Piper LLP (us). The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid and Pharmacy.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| CORVENT MEDICAL, INC. | DLA PIPER LLP (US) | Q3 2026 | Veterans, Health Issues |
| XEROX HOLDINGS CORPORATION | DLA PIPER LLP (US) | Q3 2026 | Pharmacy |
| IQVIA HOLDINGS, INC. | DLA PIPER LLP (US) | Q3 2026 | Health Issues |
| REGENXBIO INC. | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| AVALYN PHARMA INC. | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| RAINFALL HEALTH | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid |
| PONYA DIAGNOSTICS, LLC | DLA PIPER LLP (US) | Q2 2026 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | DLA PIPER LLP (US) | Q2 2026 | Trade (domestic/foreign), Budget/Appropriations, Medicare/Medicaid |
| BIOGEN, INC. | DLA PIPER LLP (US) | Q2 2026 | Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Health Issues |
| DUKE UNIVERSITY | DLA PIPER LLP (US) | Q2 2026 | Taxation/Internal Revenue Code, Education |
| AIDOC, INC. | DLA PIPER LLP (US) | Q1 2026 | Medicare/Medicaid, Health Issues |
| IRHYTHM TECHNOLOGIES, INC. | DLA PIPER LLP (US) | Q1 2026 | Medicare/Medicaid |
| DUKE UNIVERSITY HEALTH SYSTEM | DLA PIPER LLP (US) | Q4 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 12 | 1 |
| 2025 | 8 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Maren McBride. See the Capitol Clarity rankings and method.